Aurora Investment Managers LLC. Purchases Shares of 2,082 SPDR S&P Biotech ETF (NYSEARCA:XBI)

Aurora Investment Managers LLC. purchased a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 2,082 shares of the exchange traded fund’s stock, valued at approximately $206,000.

A number of other hedge funds have also recently bought and sold shares of the stock. Healthcare of Ontario Pension Plan Trust Fund boosted its stake in shares of SPDR S&P Biotech ETF by 30.3% during the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 3,136,000 shares of the exchange traded fund’s stock worth $297,575,000 after acquiring an additional 730,000 shares during the period. Northwestern Mutual Wealth Management Co. boosted its stake in shares of SPDR S&P Biotech ETF by 1.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 1,145,049 shares of the exchange traded fund’s stock worth $106,158,000 after acquiring an additional 18,202 shares during the period. Jane Street Group LLC boosted its stake in shares of SPDR S&P Biotech ETF by 68.7% during the 1st quarter. Jane Street Group LLC now owns 961,082 shares of the exchange traded fund’s stock worth $91,197,000 after acquiring an additional 391,333 shares during the period. Bessemer Group Inc. boosted its stake in shares of SPDR S&P Biotech ETF by 1.7% during the 1st quarter. Bessemer Group Inc. now owns 922,871 shares of the exchange traded fund’s stock worth $87,572,000 after acquiring an additional 15,794 shares during the period. Finally, Employees Retirement System of Texas boosted its stake in shares of SPDR S&P Biotech ETF by 40.8% during the 2nd quarter. Employees Retirement System of Texas now owns 603,857 shares of the exchange traded fund’s stock worth $55,984,000 after acquiring an additional 174,857 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.1 %

Shares of NYSEARCA XBI traded up $0.09 during midday trading on Friday, hitting $99.39. 847,423 shares of the company’s stock were exchanged, compared to its average volume of 9,467,232. SPDR S&P Biotech ETF has a 12 month low of $63.80 and a 12 month high of $103.52. The company’s 50 day moving average price is $99.00 and its 200 day moving average price is $94.31. The firm has a market capitalization of $7.58 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.